Navigation Links
Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.

Researchers at the Saint Louis University Institute for Molecular Virology (IMV) have explained in molecular terms the infection of healthy cells with HIV virus. This discovery will open new doors //for the development of drugs to prevent HIV infections throughout the world.

It is said that the HIV infection is possible because of three vital proteins.

One is the Reverse Transcriptase. Secondly it is the Integrase protein. Thirdly it is the Protease protein.

These proteins are very important at the three stages of infection. Reverse Transcriptase converts the viral RNA into DNA.

Integrase brings the ends of the DNA together and facilitates in the integration of the viral DNA into the human DNA making it as a part of the cell. This prevents the immune system to attack the virus.

Protease process viral proteins and plays an important role in the making of infectious virus.

There are various drugs like AZT and other combination drugs to inhibit Reverse Transcriptase and Protease proteins but no single drug to act on Integrase.

Fluorescence Resonance Energy Transfer is a biophysical methodology which will interrupt the activity of the Integrase of holding the two ends of the viral DNA before integration.

Once this is interrupted then there is no chance of the integration of the HIV virus DNA with the human DNA and the net result HIV infection can be prevented.

Further research plans to use this technique to develop effective drugs against HIV infection. Also drugs aiming at the assembly and disassembly process will also be researched and developed.

Page: 1

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Flaw Detected in Aggressive Breast Cancers
4. Molecular Computer Developed To perform Calculations From Within Human Body
5. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
6. Molecular Basis Of ALS Found
7. New Molecular Treatment Identified To Treat Blood Cell Cancers
8. Researchers Find Molecular "Brake" to Cell Death
9. Solitons Could Power Molecular Electronics, Artificial Muscles
10. Discovery of Agile Molecular Motors Could Aid in Treating Motor Neuron Diseases
11. Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego
Post Your Comments:

(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: